Somatic mutations of GNA11 and GNAQ in CTNNB1-mutant aldosterone-producing adenomas presenting in puberty, pregnancy or menopause
© 2021. The Author(s), under exclusive licence to Springer Nature America, Inc..
Most aldosterone-producing adenomas (APAs) have gain-of-function somatic mutations of ion channels or transporters. However, their frequency in aldosterone-producing cell clusters of normal adrenal gland suggests a requirement for codriver mutations in APAs. Here we identified gain-of-function mutations in both CTNNB1 and GNA11 by whole-exome sequencing of 3/41 APAs. Further sequencing of known CTNNB1-mutant APAs led to a total of 16 of 27 (59%) with a somatic p.Gln209His, p.Gln209Pro or p.Gln209Leu mutation of GNA11 or GNAQ. Solitary GNA11 mutations were found in hyperplastic zona glomerulosa adjacent to double-mutant APAs. Nine of ten patients in our UK/Irish cohort presented in puberty, pregnancy or menopause. Among multiple transcripts upregulated more than tenfold in double-mutant APAs was LHCGR, the receptor for luteinizing or pregnancy hormone (human chorionic gonadotropin). Transfections of adrenocortical cells demonstrated additive effects of GNA11 and CTNNB1 mutations on aldosterone secretion and expression of genes upregulated in double-mutant APAs. In adrenal cortex, GNA11/Q mutations appear clinically silent without a codriver mutation of CTNNB1.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:53 |
---|---|
Enthalten in: |
Nature genetics - 53(2021), 9 vom: 13. Sept., Seite 1360-1372 |
Sprache: |
Englisch |
---|
Links: |
---|
Anmerkungen: |
Date Completed 14.10.2021 Date Revised 20.03.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1038/s41588-021-00906-y |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM329294997 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM329294997 | ||
003 | DE-627 | ||
005 | 20240320232623.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1038/s41588-021-00906-y |2 doi | |
028 | 5 | 2 | |a pubmed24n1337.xml |
035 | |a (DE-627)NLM329294997 | ||
035 | |a (NLM)34385710 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Zhou, Junhua |e verfasserin |4 aut | |
245 | 1 | 0 | |a Somatic mutations of GNA11 and GNAQ in CTNNB1-mutant aldosterone-producing adenomas presenting in puberty, pregnancy or menopause |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 14.10.2021 | ||
500 | |a Date Revised 20.03.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2021. The Author(s), under exclusive licence to Springer Nature America, Inc. | ||
520 | |a Most aldosterone-producing adenomas (APAs) have gain-of-function somatic mutations of ion channels or transporters. However, their frequency in aldosterone-producing cell clusters of normal adrenal gland suggests a requirement for codriver mutations in APAs. Here we identified gain-of-function mutations in both CTNNB1 and GNA11 by whole-exome sequencing of 3/41 APAs. Further sequencing of known CTNNB1-mutant APAs led to a total of 16 of 27 (59%) with a somatic p.Gln209His, p.Gln209Pro or p.Gln209Leu mutation of GNA11 or GNAQ. Solitary GNA11 mutations were found in hyperplastic zona glomerulosa adjacent to double-mutant APAs. Nine of ten patients in our UK/Irish cohort presented in puberty, pregnancy or menopause. Among multiple transcripts upregulated more than tenfold in double-mutant APAs was LHCGR, the receptor for luteinizing or pregnancy hormone (human chorionic gonadotropin). Transfections of adrenocortical cells demonstrated additive effects of GNA11 and CTNNB1 mutations on aldosterone secretion and expression of genes upregulated in double-mutant APAs. In adrenal cortex, GNA11/Q mutations appear clinically silent without a codriver mutation of CTNNB1 | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 7 | |a CTNNB1 protein, human |2 NLM | |
650 | 7 | |a GNA11 protein, human |2 NLM | |
650 | 7 | |a GNAQ protein, human |2 NLM | |
650 | 7 | |a GTP-Binding Protein alpha Subunits |2 NLM | |
650 | 7 | |a beta Catenin |2 NLM | |
650 | 7 | |a Aldosterone |2 NLM | |
650 | 7 | |a 4964P6T9RB |2 NLM | |
650 | 7 | |a GTP-Binding Protein alpha Subunits, Gq-G11 |2 NLM | |
650 | 7 | |a EC 3.6.5.1 |2 NLM | |
700 | 1 | |a Azizan, Elena A B |e verfasserin |4 aut | |
700 | 1 | |a Cabrera, Claudia P |e verfasserin |4 aut | |
700 | 1 | |a Fernandes-Rosa, Fabio L |e verfasserin |4 aut | |
700 | 1 | |a Boulkroun, Sheerazed |e verfasserin |4 aut | |
700 | 1 | |a Argentesi, Giulia |e verfasserin |4 aut | |
700 | 1 | |a Cottrell, Emily |e verfasserin |4 aut | |
700 | 1 | |a Amar, Laurence |e verfasserin |4 aut | |
700 | 1 | |a Wu, Xilin |e verfasserin |4 aut | |
700 | 1 | |a O'Toole, Sam |e verfasserin |4 aut | |
700 | 1 | |a Goodchild, Emily |e verfasserin |4 aut | |
700 | 1 | |a Marker, Alison |e verfasserin |4 aut | |
700 | 1 | |a Senanayake, Russell |e verfasserin |4 aut | |
700 | 1 | |a Garg, Sumedha |e verfasserin |4 aut | |
700 | 1 | |a Åkerström, Tobias |e verfasserin |4 aut | |
700 | 1 | |a Backman, Samuel |e verfasserin |4 aut | |
700 | 1 | |a Jordan, Suzanne |e verfasserin |4 aut | |
700 | 1 | |a Polubothu, Satyamaanasa |e verfasserin |4 aut | |
700 | 1 | |a Berney, Daniel M |e verfasserin |4 aut | |
700 | 1 | |a Gluck, Anna |e verfasserin |4 aut | |
700 | 1 | |a Lines, Kate E |e verfasserin |4 aut | |
700 | 1 | |a Thakker, Rajesh V |e verfasserin |4 aut | |
700 | 1 | |a Tuthill, Antoinette |e verfasserin |4 aut | |
700 | 1 | |a Joyce, Caroline |e verfasserin |4 aut | |
700 | 1 | |a Kaski, Juan Pablo |e verfasserin |4 aut | |
700 | 1 | |a Karet Frankl, Fiona E |e verfasserin |4 aut | |
700 | 1 | |a Metherell, Lou A |e verfasserin |4 aut | |
700 | 1 | |a Teo, Ada E D |e verfasserin |4 aut | |
700 | 1 | |a Gurnell, Mark |e verfasserin |4 aut | |
700 | 1 | |a Parvanta, Laila |e verfasserin |4 aut | |
700 | 1 | |a Drake, William M |e verfasserin |4 aut | |
700 | 1 | |a Wozniak, Eva |e verfasserin |4 aut | |
700 | 1 | |a Klinzing, David |e verfasserin |4 aut | |
700 | 1 | |a Kuan, Jyn Ling |e verfasserin |4 aut | |
700 | 1 | |a Tiang, Zenia |e verfasserin |4 aut | |
700 | 1 | |a Gomez Sanchez, Celso E |e verfasserin |4 aut | |
700 | 1 | |a Hellman, Per |e verfasserin |4 aut | |
700 | 1 | |a Foo, Roger S Y |e verfasserin |4 aut | |
700 | 1 | |a Mein, Charles A |e verfasserin |4 aut | |
700 | 1 | |a Kinsler, Veronica A |e verfasserin |4 aut | |
700 | 1 | |a Björklund, Peyman |e verfasserin |4 aut | |
700 | 1 | |a Storr, Helen L |e verfasserin |4 aut | |
700 | 1 | |a Zennaro, Maria-Christina |e verfasserin |4 aut | |
700 | 1 | |a Brown, Morris J |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Nature genetics |d 1992 |g 53(2021), 9 vom: 13. Sept., Seite 1360-1372 |w (DE-627)NLM012651230 |x 1546-1718 |7 nnns |
773 | 1 | 8 | |g volume:53 |g year:2021 |g number:9 |g day:13 |g month:09 |g pages:1360-1372 |
856 | 4 | 0 | |u http://dx.doi.org/10.1038/s41588-021-00906-y |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 53 |j 2021 |e 9 |b 13 |c 09 |h 1360-1372 |